Somnigroup International
SGI
61.76
-0.98
-1.56%
Somnigroup International
US · SGI
#1166 by market cap
Listed 1970
61.76
-0.98
-1.56%
Live - 5344 symbols - heartbeat 200s ago
· 2026-10-08 07:34
Pre-market
61.42
-0.55%
After-hours
61.76
0.00%
- Market cap
- 14.22B
- P/E (TTM)i
- 24.41
- P/Bi
- 4.40
- EPSi
- 1.84
- Div yieldi
- 1.04%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on SGI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.30, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +51.63% YoY
Margins
- Gross margin
- 42.58%
- Operating margin
- 10.02%
- Net margin
- 5.14%
Key ratios & quality
- Enterprise valuei
- 19.17B
- Altman Z-Scorei
- 2.30
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.70B | 3.11B | 3.68B | 4.93B | 4.92B | 4.93B | 4.93B | 7.48B |
| Gross profit | 1.12B | 1.34B | 1.64B | 2.16B | 2.05B | 1.99B | 2.03B | 3.18B |
| Selling & admin expenses | 882.00M | 1.01B | 1.12B | 1.28B | 1.39B | 1.40B | 1.41B | 2.43B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 238.70M | 330.80M | 515.70M | 881.70M | 659.50M | 584.20M | 615.30M | 749.20M |
| Pretax profit | 165.00M | 265.50M | 452.40M | 824.00M | 577.20M | 474.10M | 504.30M | 481.00M |
| Tax | 49.60M | 74.70M | 102.60M | 198.30M | 119.00M | 103.40M | 118.60M | 95.70M |
| Net profit | 97.60M | 189.40M | 349.80M | 625.00M | 457.80M | 370.70M | 385.70M | 385.30M |
| Basic EPS | 0 | 1 | 2 | 3 | 3 | 2 | 2 | 2 |
| Diluted EPS | 0.46 | 0.86 | 1.64 | 3.06 | 2.53 | 2.08 | 2.16 | 1.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.60B | 1.88B | 2.12B | 1.87B | 1.80B | 1.82B |
| Gross profit | 580.50M | 827.20M | 952.80M | 822.70M | 776.90M | 817.20M |
| Selling & admin expenses | 572.10M | 636.40M | 641.20M | 584.30M | 595.40M | 618.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 8.40M | 190.80M | 311.60M | 238.40M | 181.50M | 198.60M |
| Pretax profit | -49.30M | 102.70M | 233.90M | 193.70M | 137.30M | 147.80M |
| Tax | -16.50M | 3.20M | 56.20M | 52.80M | 33.40M | 37.20M |
| Net profit | -32.80M | 99.50M | 177.70M | 140.90M | 103.90M | 110.60M |
| Basic EPS | 0 | 0 | 1 | 1 | 1 | 1 |
| Diluted EPS | -0.17 | 0.47 | 0.83 | 0.66 | 0.49 | 0.52 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 805.40M | 900.20M | 968.40M | 1.28B | 1.20B | 1.10B | 1.07B | 1.29B |
| Cash & ST investments | 45.80M | 64.90M | 65.00M | 300.70M | 69.40M | 74.90M | 117.40M | 134.90M |
| Inventory | 222.30M | 260.50M | 312.10M | 463.90M | 555.00M | 483.10M | 447.00M | 630.00M |
| Total assets | 2.72B | 3.06B | 3.31B | 4.32B | 4.36B | 4.55B | 5.98B | 11.60B |
| Total current liabilities | 669.00M | 773.30M | 974.80M | 1.05B | 981.20M | 908.20M | 960.30M | 1.57B |
| Short-term debt | 47.10M | 88.20M | 104.90M | 154.70M | 175.90M | 164.50M | 196.30M | 512.00M |
| Long-term debt | 1.60B | 1.50B | 1.32B | 2.28B | 2.74B | 2.53B | 3.74B | 4.57B |
| Total liabilities | 2,497,900,000.00 | 2,701,400,000.00 | 2,795,100,000.00 | 4,028,400,000.00 | 4,372,100,000.00 | 4,220,500,000.00 | 5,412,100,000.00 | 8,483,800,000.00 |
| Total equity | 217.50M | 360.40M | 513.50M | 295.00M | -12.30M | 333.40M | 568.30M | 3.12B |
| Retained earnings | 1.51B | 1.70B | 2.05B | 2.60B | 2.99B | 3.28B | 3.57B | 3.83B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.42B | 1.39B | 1.31B | 1.29B | 1.25B | 1.29B |
| Cash & ST investments | 111.10M | 98.10M | 100.20M | 134.90M | 110.80M | 112.00M |
| Inventory | 680.80M | 709.60M | 645.10M | 630.00M | 631.00M | 649.80M |
| Total assets | 11.33B | 11.38B | 11.40B | 11.60B | 11.54B | 11.61B |
| Total current liabilities | 1.69B | 1.68B | 1.74B | 1.57B | 1.61B | 1.72B |
| Short-term debt | 490.30M | 490.70M | 509.50M | 512.00M | 512.80M | 520.90M |
| Long-term debt | 4.92B | 4.80B | 4.41B | 4.57B | 4.44B | 4.29B |
| Total liabilities | 8,579,400,000.00 | 8,526,200,000.00 | 8,405,200,000.00 | 8,483,800,000.00 | 8,384,300,000.00 | 8,374,000,000.00 |
| Total equity | 2.75B | 2.85B | 2.99B | 3.12B | 3.16B | 3.24B |
| Retained earnings | 3.51B | 3.57B | 3.72B | 3.83B | 3.90B | 3.97B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 183.10M | 314.80M | 654.70M | 723.10M | 378.80M | 570.30M | 666.50M | 800.10M |
| Depreciation & amortization | 87.10M | 89.70M | 98.00M | 113.20M | 127.10M | 135.30M | 165.10M | 249.50M |
| Free cash flow | 109.50M | 226.60M | 543.40M | 599.80M | 72.30M | 384.90M | 569.20M | 633.20M |
| Dividends paid | -- | 0 | 0 | -63.10M | -70.50M | -77.70M | -92.70M | -127.40M |
| Stock buybacks / issuance | -4.60M | -105.70M | -331.80M | -816.30M | -667.40M | -36.00M | -43.80M | -132.40M |
| Ending cash balance | 45.80M | 64.90M | 65.00M | 300.70M | 69.40M | 74.90M | 1.71B | 134.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 106.40M | 186.10M | 408.20M | 99.40M | 246.50M | 236.30M |
| Depreciation & amortization | 57.70M | 58.50M | 63.80M | 69.50M | 60.90M | 62.40M |
| Free cash flow | 82.40M | 149.40M | 360.30M | 41.10M | 186.00M | 181.60M |
| Dividends paid | -32.90M | -31.50M | -31.50M | -31.50M | -36.70M | -35.80M |
| Stock buybacks / issuance | -37.50M | -94.90M | 0 | 0 | -26.20M | 0 |
| Ending cash balance | 111.10M | 98.10M | 100.20M | 134.90M | 110.80M | 112.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 61.45 | 66.02 | 80.82 | 158.22 | 345.62 | 244.34 | 87.10 | 20.95 |
| ROA %i | 3.72 | 6.56 | 10.95 | 16.37 | 10.50 | 8.26 | 7.30 | 4.37 |
| ROIC %i | 8.86 | 12.50 | 18.72 | 25.21 | 16.56 | 13.54 | 11.31 | 8.08 |
| 5-year avg ROE %i | 151.75 | 151.39 | 162.32 | 162.89 | 142.43 | 179.00 | 183.22 | 171.25 |
| EBIT margin %i | 9.52 | 11.31 | 14.40 | 18.06 | 13.82 | 12.26 | 12.96 | 10.02 |
| FCF / sales %i | 4.05 | 7.23 | 14.79 | 12.16 | 1.47 | 7.81 | 11.54 | 8.47 |
| Current ratioi | 1.20 | 1.16 | 0.99 | 1.21 | 1.22 | 1.21 | 1.11 | 0.83 |
| Quick ratioi | 0.55 | 0.56 | 0.46 | 0.68 | 0.50 | 0.56 | 0.54 | 0.32 |
| Debt / assetsi | 60.62 | 58.66 | 51.47 | 66.16 | 77.28 | 71.73 | 74.72 | 57.54 |
| LT debt / equityi | 745.15 | 475.10 | 317.34 | 946.64 | -- | 959.12 | 764.31 | 198.30 |
| Interest coveragei | 2.79 | 4.10 | 6.88 | 13.43 | 6.60 | 4.65 | 4.74 | 2.80 |
| Revenue CAGR (3Y) %i | -5.02 | 0.28 | 10.83 | 22.19 | 16.58 | 10.24 | 0.00 | 14.96 |
| Net income CAGR (3Y) %i | 15.93 | -0.19 | 32.07 | 83.85 | 33.97 | 1.81 | -14.94 | -5.54 |
| FCF CAGR (3Y) %i | -13.35 | 29.81 | 51.49 | 76.28 | -31.67 | -10.86 | -1.73 | 106.13 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 17.92 | 16.47 | 17.76 | 20.95 | 17.71 | 17.57 |
| ROA %i | 3.45 | 3.36 | 3.95 | 4.37 | 4.56 | 4.64 |
| ROIC %i | 6.03 | 6.59 | 7.83 | 8.08 | 7.54 | 7.48 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.71 | 8.69 | 9.14 | 10.02 | 12.17 | 12.68 |
| FCF / sales %i | 10.34 | 9.68 | 10.27 | 8.47 | 9.60 | 10.10 |
| Current ratioi | 0.84 | 0.82 | 0.75 | 0.83 | 0.78 | 0.75 |
| Quick ratioi | 0.27 | 0.27 | 0.29 | 0.32 | 0.28 | 0.27 |
| Debt / assetsi | 61.25 | 60.16 | 58.08 | 57.54 | 56.63 | 55.22 |
| LT debt / equityi | 235.20 | 223.62 | 204.72 | 198.30 | 191.32 | 182.42 |
| Interest coveragei | 3.21 | 2.59 | 2.60 | 2.80 | 3.50 | 3.82 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Mattress Firm is the largest reported line at 50.77% of revenue, across 4 reported segments.
- Tempur Sealy North America follows at 49.13%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Mattress Firm50.77%
Tempur Sealy North America49.13%
Tempur Sealy International16.43%
Quote time 2026-10-08 07:34:43 · For reference only, not investment advice and not tailored to your situation.